Enoxaparin Therapy for Arterial Thrombosis After Umbilical Cord Catheterization in Preterm Infants.
- Author:
Yoon Joo KIM
1
;
Young Don KIM
;
Jae Hong CHOI
Author Information
- Publication Type:Case Report
- Keywords: Preterm infants; Enoxaparin; Arterial thrombosis; Umbilical artery catheter
- MeSH: Catheterization*; Catheters*; Enoxaparin*; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Incidence; Infant, Newborn; Infant, Premature*; Thrombectomy; Thrombosis*; Umbilical Cord*
- From:Neonatal Medicine 2016;23(2):121-126
- CountryRepublic of Korea
- Language:Korean
- Abstract: The incidence of symptomatic thrombosis of umbilical arterial catheterization is 1-3%. Therapeutic options may include: using heparin or low molecular weight heparin, using a thrombolytic agent, or surgical thrombectomy. However, there are insufficient data to recommend any one treatment over the others. Recently, enoxaparin, a low molecular weight heparin, has emerged as a drug of choice for the treatment of neonatal thrombosis due to pharmacologic stability over unfractionated heparin or thrombolytic agents. We report a case of successful treatment of aortic thrombosis after umbilical arterial catheterization with enoxaparin in preterm infants.
